Ignite Creation Date:
2025-12-24 @ 11:41 PM
Ignite Modification Date:
2026-03-01 @ 12:05 PM
Study NCT ID:
NCT03057951
Status:
COMPLETED
Last Update Posted:
2022-06-06
First Post:
2017-02-16
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)
Sponsor:
Boehringer Ingelheim
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-03-02
Start Date Type:
ACTUAL
Primary Completion Date:
2021-04-26
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-04-26
Completion Date Type:
ACTUAL
First Submit Date:
2017-02-16
First Submit QC Date:
None
Study First Post Date:
2017-02-20
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2022-04-20
Results First Submit QC Date:
None
Results First Post Date:
2022-06-06
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-06-03
Last Update Post Date:
2022-06-06
Last Update Post Date Type:
ACTUAL